Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan

Overview of attention for article published in Arthritis Research & Therapy, October 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Interferon and B-cell signatures inform precision medicine in lupus nephritis

Article in Kidney International Reports (March 2024)

Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation

Article in BMC Research Notes (October 2023)

Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy

Article in Scandinavian Journal of Rheumatology (November 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.